Anti-NMDA Receptor Encephalitis synonyms

Anti-NMDA receptor encephalitis is most commonly referred to by its full name or the abbreviation Anti-NMDAR encephalitis, though it is sometimes historically labeled as anti-glutamate receptor encephalitis. It is a rare autoimmune disorder characterized by the body’s immune system attacking NMDA receptors in the brain, often requiring precise identification in medical records to ensure appropriate care.

What are the common names and synonyms for Anti-NMDA receptor encephalitis?

While Anti-NMDA receptor encephalitis is the standard terminology, patients may encounter several variations in medical literature or clinical notes. Because the condition involves antibodies targeting the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor, it is occasionally referred to as anti-NR1 encephalitis. Older literature or specialized neurology reports may use the following:

• Anti-NMDAR encephalitis (the most common clinical abbreviation)


• Anti-NMDA receptor antibody encephalitis


• Anti-glutamate receptor encephalitis (a broader, less specific historical term)


• NMDAR antibody-mediated encephalitis

How is the condition classified in medical systems?

Standardized medical systems provide specific identifiers to help clinicians track Anti-NMDA receptor encephalitis accurately. These codes are essential for insurance and specialized care coordination:

1. Orphanet: Classified under ORPHA:217192.


2. ICD-10-CM: Often coded under G04.81 (Other encephalitis).


3. OMIM: Documented as a specific autoimmune manifestation, though it does not always have a single Mendelian entry as it is an acquired, not strictly genetic, condition.

Why does this condition have multiple names?

The naming of Anti-NMDA receptor encephalitis has evolved alongside our understanding of neuroimmunology. Originally, the condition was grouped under general autoimmune encephalitis. As researchers identified the specific target—the NMDA receptor—the nomenclature became more precise. Anti-NMDA receptor encephalitis is the preferred term today because it directly describes the pathological mechanism: the presence of autoantibodies against the NMDA receptor.

Is this name usage important for patient care?

Yes, using the correct terminology for Anti-NMDA receptor encephalitis is vital when communicating with specialists or searching for research. With 76 members in the DiseaseMaps.org community living with this diagnosis, we have seen that clarity in documentation helps patients access the right clinical trials and peer-reviewed studies. Always ensure your medical records specify Anti-NMDA receptor encephalitis to avoid confusion with other forms of autoimmune or viral encephalitis.

Next steps

• Consult a neuro-immunologist to confirm your specific diagnosis and antibody profile.


• Join our community of 76 members at DiseaseMaps.org to share experiences and find peer support.


• Request that your neurologist use the term Anti-NMDA receptor encephalitis in all referral letters to maintain consistency.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: https://www.orpha.net/ (Search: ORPHA:217192)


• NIH GARD (Genetic and Rare Diseases Information Center): https://rarediseases.info.nih.gov/


• OMIM (Online Mendelian Inheritance in Man): https://www.omim.org/


• The Encephalitis Society: https://www.encephalitis.info/